[Comparative study of heparin and a very low molecular-weight heparin in hemodialysis in chronic renal insufficiency]

Presse Med. 1987 May 23;16(19):955-8.
[Article in French]

Abstract

In the course of dialysis sessions, we have compared the antithrombotic effect of two heparinization regimens: low molecular weight heparin (CY 222, mean molecular weight: 2,500, Institute Choay, France): 90 anti-Xa units/kg bodyweight as a bolus injection followed by a continuous infusion of 1,000 anti-Xa units/hour (regimen 1); or 300 anti-Xa units/kg as a bolus injection (regimen 3), with a standard heparinization regimen (100 IU/kg regimen 2). Eight patients received the 3 regimens successively. Factor IIa and factor Xa inactivation was measured by a method that uses chromogenic substrates. The frequency of adverse effects, ultrafiltration rates, creatinine and BUN clearances of the 3 regimens were similar, whereas dialyser blood loss was higher in the first regimen. At the dose of 300 anti-Xa units of CY 222 (regimen 3), inactivation of factor Xa was similar to Xa inhibition reached through the conventional treatment (regimen 2) but IIa inhibition was less pronounced.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Evaluation Studies as Topic
  • Hemostasis / drug effects
  • Heparin / therapeutic use*
  • Humans
  • Kidney Failure, Chronic / therapy*
  • Middle Aged
  • Molecular Weight
  • Renal Dialysis*
  • Thrombosis / prevention & control*

Substances

  • Heparin